Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
James J LeeSandra M Swain

Abstract

To investigate baseline factors and neurologic function tests (NFTs) that may predict the development of grade 2 or higher peripheral neuropathy (PN) after treatment with ixabepilone, an epothilone microtubule-stabilizing agent with antitumor activity. Advanced breast cancer patients were treated with ixabepilone (6 mg/m2) for 5 consecutive days every 3 weeks in a phase II clinical trial. Physical examinations, questionnaires, nerve conduction studies, and NFTs, including the Jebsen Test of Hand Function (JTH) and the Grooved Pegboard Test (GPT), were performed at baseline and during subsequent cycles. Forty-seven patients assessable for PN received a median of five cycles of therapy (range, one to 22 cycles). Nine of these patients developed grade 2 PN, and two developed grade 3 PN, with a median time to onset of 144 days (range, 6 to 189 days). Among these 11 patients, PN resolved in eight patients, with a median of 15 days (range, 6 to 346 days) after onset, but PN did not resolve in three patients during follow-ups at 76, 361, and 746 days after onset. GPT and changes of JTH scores at onset of PN were significantly different between patients with and without PN at comparable follow-up times (P = .006 and P = .002, respectiv...Continue Reading

References

Sep 1, 1991·Southern Medical Journal·J E CasanovaM J Young
Oct 1, 1984·Journal of Neurocytology·M RöyttäC S Raine
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Jan 1, 1981·Cancer·A B MillerA Winkler
Jul 21, 1993·Journal of the National Cancer Institute·M D BrundageB Zee
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M NabholtzB Winograd
Oct 1, 1997·Journal of Neuro-oncology·P A ForsythL M DeAngelis
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T J PostmaN K Aaronson
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D SeidmanL Norton
Jul 7, 2000·Foot & Ankle International·C JengM Mizel
Jul 25, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T J Postma, J J Heimans
Mar 10, 2001·Archives of Physical Medicine and Rehabilitation·E A HurvitzR A Werner
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jame AbrahamTito Fojo
Sep 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O SmaletzW K Kelly
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sridhar ManiSusan Band Horwitz
Mar 9, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Antonio Nardone, Marco Schieppati
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan GoodinEric H Rubin
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C EngE E Vokes
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric P WinerLarry Norton
Jan 12, 2005·Journal of Diabetes and Its Complications·Nozomu KameiNobuoki Kohno
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R BuchananLori M Minasian
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew D GalskyW Kevin Kelly
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A LowSandra M Swain
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott OkunoCharles Erlichman
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maha HussainUNKNOWN Southwest Oncology Group

❮ Previous
Next ❯

Citations

Jul 19, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Joan Elizabeth CunninghamSteve H Chin
Aug 27, 2009·Nature Reviews. Clinical Oncology·David SchiffMartin J van den Bent
Oct 5, 2010·Nature Reviews. Drug Discovery·Charles Dumontet, Mary Ann Jordan
Jul 23, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S GoelS Mani
Jan 7, 2010·American Journal of Clinical Oncology·Seema Harichand-Herdt, Ruth M O'regan
Aug 27, 2009·Biologics : Targets & Therapy·Shannon Puhalla, Adam Brufsky
Apr 13, 2013·Physiology Journal·Elena G Zotova, Joseph C Arezzo
Mar 28, 2008·Expert Opinion on Investigational Drugs·Xavier PivotChristophe Borg
Mar 7, 2008·Expert Opinion on Investigational Drugs·Neelima Denduluri, Sandra M Swain
Sep 13, 2011·Critical Reviews in Oncology/hematology·Andreas A ArgyriouGuido Cavaletti
May 31, 2011·Journal of Pain and Symptom Management·Andreas A ArgyriouHaralabos P Kalofonos
May 26, 2009·Neurobiology of Disease·Alessia ChiorazziGuido Cavaletti
Feb 2, 2010·Clinical Journal of Oncology Nursing·Alisha Stein
May 22, 2010·Neurología : publicación oficial de la Sociedad Española de Neurología·R Velasco, J Bruna
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neelima DenduluriSandra M Swain
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca Gianni
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henri RochéHervé Curé
Jan 28, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Laura Boehnke Michaud
Feb 10, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ami TabataToshihiro Kato
Mar 19, 2008·Journal of the Peripheral Nervous System : JPNS·Anthony J Windebank, Wolfgang Grisold
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yue-Ming WangJian-Dong Jiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Neelima DenduluriSandra M Swain
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Laura Boehnke Michaud
© 2022 Meta ULC. All rights reserved